Bladder cancer is the second most common genitourinary malignancy and accounts for approximately 70 000 new diagnoses and 16 000 deaths each year in the USA. Bladder cancer is considered the most expensive cancer to care for on a per patient basis given the need for frequent cystoscopic surveillance. There are three major clinically relevant disease states of bladder cancer: non-muscle-invasive disease, muscle-invasive disease, and metastatic disease. The major goals of treatment for each of these disease states are to achieve cancer control and prevent progression to the next disease state while limiting treatment-related morbidity.

Original languageEnglish
Title of host publicationOncology
Number of pages11
ISBN (Electronic)9781119189596
ISBN (Print)9781119189558
StatePublished - 30 Aug 2019


  • Asymptomatic microscopic hematuria
  • Bladder cancer
  • Diagnostic algorithms
  • Evidence-based clinical data
  • Smoking cessation
  • Transurethral resection
  • Treatment algorithms


Dive into the research topics of 'Bladder cancer'. Together they form a unique fingerprint.

Cite this